TISSIUM Revenue and Competitors
Estimated Revenue & Valuation
- TISSIUM's estimated annual revenue is currently $36.4M per year.
- TISSIUM's estimated revenue per employee is $251,000
Employee Data
- TISSIUM has 145 Employees.
- TISSIUM grew their employee count by 9% last year.
TISSIUM's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Advisor, VP Sales & Marketing | Reveal Email/Phone |
3 | Head Nerve Solutions | Reveal Email/Phone |
4 | VP Portfolio Strategy | Reveal Email/Phone |
5 | VP Global Operations | Reveal Email/Phone |
6 | Director Innovation & Strategy | Reveal Email/Phone |
7 | Senior Director, Preclinical | Reveal Email/Phone |
8 | Associate Marketing Director | Reveal Email/Phone |
9 | Senior Director ,Professional Education | Reveal Email/Phone |
10 | Director Innovation & Concept Development | Reveal Email/Phone |
TISSIUM Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31.6M | 126 | 9% | N/A | N/A |
#2 | $65.8M | 262 | 3% | N/A | N/A |
#3 | $55.7M | 222 | 47% | N/A | N/A |
#4 | $43.4M | 173 | -9% | N/A | N/A |
#5 | $32.4M | 129 | 5% | N/A | N/A |
#6 | $115M | 458 | 9% | N/A | N/A |
#7 | $36.4M | 145 | 9% | N/A | N/A |
#8 | $143.7M | 409 | -11% | €83.1M | N/A |
#9 | $32.4M | 129 | 2% | N/A | N/A |
#10 | $2571.2M | 10244 | 4% | N/A | N/A |
What Is TISSIUM?
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully integrated innovation, design, commercialization and manufacturing platform to support our internal programs as well as co-development partnerships with leaders in the medtech industry.
keywords:N/A
N/A
Total Funding
145
Number of Employees
$36.4M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TISSIUM News
TISSIUM, a privately-owned medtech company based in Paris, France and Boston, USA is dedicated to the development and commercialization of...
Paris-based Tissium has raised €50 million in a round led by Cathay Capital and Sofinnova Partners. The startup develops biodegradable sealants and adhesives for tissue repair and reconstruction. The funds bring the company closer to the commercialization of its leading products. View details
Paris, France, August 31, 2021 – TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced it has closed a Series C round of financing, raising €50 million from new and existing international investors. Cathay Health, affiliated t ...
Paris-based Tissium, a privately-owned medtech company that develops biomorphic programmable polymers for tissue reconstruction, announced that it has raised €50M in its Series C round of funding.Investors in this round The round was led by Cathay Health, affiliated to investment firm Cathay Ca ...
Other Companies in Paris
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 145 | 14% | N/A |
#2 | $23.9M | 145 | 7% | N/A |
#3 | $43.4M | 146 | 25% | N/A |
#4 | $35.3M | 146 | -3% | N/A |
#5 | N/A | 146 | 4% | N/A |